Dr. King’s Fear of the White Moderate Still Applies to HIV and LGBTQ Organizations
Advocate D. Rashaan Gilmore explains how white-led HIV organizations in the U.S. engage in movement capture—e.g., the co-opting of Black racial justice efforts—under the guise of ending the HIV epidemic.
This Week in HIV Research: Just a Text Away
Jan. 16, 2020: Texting (and stigma support) vs. email for care retention; beyond-childhood health risks for HIV-exposed infants; HIV, cardiovascular risk, and cognitive impairment; direct-acting antiviral efficacy and prescription delays.
FDA Rejects Injectable HIV Treatment, but Not Due to Drug Safety
This may be a temporary setback, but long-acting antiretroviral therapy is still on the way, experts say.
How One Nurse Practitioner Builds Relationships to Boost HIV Suppression
“I’m not a physician. … We can diagnose and treat, but fundamentally we are taught to care.”
Our Newest Posts
One-Two Punch of Antibodies and Antiretrovirals Stops HIV Infection in Primate Infants
While it is too soon to tell, this research involving broadly neutralizing antibodies could point to new methods for preventing vertical transmission.
Despite ART, Immune System Ages Faster Among People Living With HIV, Study Finds
Even with an undetectable viral load, study participants who had been vaccinated as children lost smallpox immunity.
This Week in HIV Research: Bone Concerns Aren’t Just for Older Folks
Jan. 9, 2020: Bone loss after HIV treatment initiation; aging and antiretroviral dosage; more U=U evidence for women; viral suppression and executive function.
New York City Makes Strides in HIV Diagnosis Times, More Work Ahead
Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
This Week in HIV Research: A New Year, an Old Enemy
Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.
What's New in U.S. HIV Clinical Treatment Guidelines
We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV.
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
